CDKN2A promoter methylation and hepatocellular carcinoma risk: A meta-analysis

This publication has 74 references indexed in Scilit:

• Cellular senescence and tumor suppressor gene p16
  International Journal of Cancer, 2011
• P16gene hypermethylation and hepatocellular carcinoma: A systematic review and meta-analysis
  World Journal of Gastroenterology, 2011
• Comparative analysis of promoter methylation and gene expression endpoints between tumorous and non-tumorous tissues from HCV-positive patients with hepatocellular carcinoma
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2010
• Promoter methylation of CDKN2A and lack of p16 expression characterize patients with hepatocellular carcinoma
  BMC Cancer, 2010
• DNA methylation changes in normal liver tissues and hepatocellular carcinoma with different viral infection
  Experimental and Molecular Pathology, 2010
• Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma
  Hepatology, 2008
• Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma
  British Journal of Cancer, 2007
• Methylation-based molecular margin analysis in hepatocellular carcinoma
  Biochemical and Biophysical Research Communications, 2005
• Measuring inconsistency in meta-analyses
  BMJ, 2003
• A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
  Nature, 1993